Skip to main content

Table 1 Baseline characteristics and magnesium status of study participants

From: Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions: analysis of a large real-world dataset

  Pregnant women (N = 983) Women with hormone-related conditions
Hormonal contraception (n = 1562) Premenstrual syndrome (n = 1549) Climacteric syndromea,b (n = 1618) HRTb (n = 1555) Osteoporosis (n = 1625) Otherc (n = 1535) Total (N = 9444)
Age, years
 n/missing 983/0 1562/0 1549/0 1618/0 1555/0 1625/0 1535/0 9444/0
 Median 28.0 30.0 29.0 51. 50.0 55.0 36.0 44.0
 Q1; Q3 25.0; 32.0 25.0; 34.0 25.0; 35.0 48.0; 54.0 47.0; 54.0 51.0; 58.0 30.0; 42.0 31.0; 52.0
 Min; Max 18; 52 18; 55 18; 56 29; 60 23; 60 19; 60 18; 59 18; 60
BMI, kg/m2
 n/missing 983/0 1554/8 1540/9 1609/9 1546/9 1620/5 1532/3 9401/43
 Median 23.10 22.10 22.40 27.20 26.30 27.10 24.20 25.00
 Q1; Q3 20.90; 26.40 20.30; 24.60 20.30; 25.20 24.70; 30.50 24.00; 29.00 24.30; 30.50 21.80; 27.40 22.00; 28.30
 Min; Max 15.9; 50.3 14.6; 48.5 15.6; 43.7 15.2; 63.4 13.8; 60.6 15.2; 51.8 14.8; 52.1 13.8; 63.4
Total blood serum magnesium, mmol/L
 n/missing 983/0 1562/0 1549/0 1618/0 1555/0 1625/0 1535/0 9444/0
 Mean (SD) 0.714 (0.125) 0.789 (0.197) 0.787 (0.193) 0.765 (0.198) 0.787 (0.219) 0.758 (0.199) 0.771 (0.180) 0.776 (0.198)
 Median 0.700 0.780 0.790 0.750 0. 780 0.750 0.770 0.770
 Q1; Q3 0.650; 0.780 0.680; 0.900 0.680; 0.890 0.650; 0.860 0.680; 0.890 0.640; 0.860 0.660; 0.890 0.660; 0.890
 Min; Max 0.12; 1.92 0.09; 2.41 0.14; 2.50 0.20; 2.50 0.10; 4.08 0.20; 2.20 0.08; 2.50 0.08; 4.08
  1. BMI Body mass index, HRT Hormone replacement therapy, Q Quartile
  2. aWomen with climacteric syndrome not receiving HRT
  3. bIncluding surgical menopause
  4. cWomen of reproductive age with other hormonal conditions: endometriosis, polycystic ovarian disease, uterine leiomyoma, dysmenorrhea, endometrial hyperplasia